CARE Ratings (CARERATING) Fundamentals 2026 — P/E 29.4x, Revenue Analysis | SniperIQ
CARE Ratings (CARERATING) is a India-listed Financial Services company in Financial - Data & Stock Exchanges with a market capitalization of ₹5,063 Crore, trading at ₹1674.15 on the BSE. This SniperIQ fundamentals page covers CARE Ratings's valuation (P/E 29.4x, P/B 1.7x), profitability (net margin 36.2%), revenue (₹473 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is CARE Ratings's market cap?
CARE Ratings (CARERATING) has a market capitalization of approximately ₹5,063 Crore, trading at ₹1674.15 on the BSE. Market cap moves with the live share price.
What is CARE Ratings's P/E ratio?
CARE Ratings's trailing twelve-month P/E ratio is 29.4x, with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is CARE Ratings?
CARE Ratings runs a net profit margin of 36.2%, a gross margin of 50.3%, and an operating margin of 38.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does CARE Ratings generate?
CARE Ratings reported revenue of ₹473 Crore for fiscal year 2026, with net income of ₹171 Crore and earnings per share (EPS) of 17.58. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does CARE Ratings pay a dividend?
CARE Ratings offers a trailing dividend yield of about 1.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is CARE Ratings financially healthy?
CARE Ratings carries a debt-to-equity ratio of 0.03x and a current ratio of 5.76x, with a market beta of 0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is CARE Ratings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CARE Ratings (CARERATING) the key facts are: market cap ₹5,063 Crore, P/E 29.4x, revenue ₹473 Crore, 52-week range 1393.95-1856.65. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track CARE Ratings's full fundamentals live
Get CARE Ratings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.